your market intelligence analyst
Search Results
231 results
Your search is now limited to «Eli Lilly» expert search. 07/19/2019 01:34
Global Myocardial Infarction Drugs Market report is first of its kind research report that incorporates the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the worldwide market.
More from
FiercePharmaManufacturing 07/17/2019 09:09
In breast cancer, Novartis’ Kisqali is trailing closely behind Eli Lilly’s direct competitor Verzenio.
More from FiercePharmaManufacturing:
PR Newswire 07/13/2019 06:45
Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve upon the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
More from PR Newswire:
Dr. Lipton serves as a consultant and advisory board member and has received honoraria from Eli Lilly and Company.
More from Healthcare Sales & Marketing Network:
pharmaphorum 07/12/2019 03:28
Christi Shaw, president of Eli Lilly Bio-Medicines is leaving the company after two years, taking the top job at Gilead’s Kite cancer immunotherapy unit.
More from pharmaphorum:
ENDPOINTS 07/11/2019 16:59
We found out Thursday evening that Christi Shaw has given up her top post as the head of the Bio-Medicines group at Eli Lilly for the helm at CAR-T pioneer Kite.
More from ENDPOINTS:
Becker's Hospital Review 07/11/2019 13:57
Eli Lilly also announced its general counsel, Mike Harrington, will retire at the end of the year.
More from Becker's Hospital Review: 07/11/2019 09:13
Adds exec background, announcement details) July 11 (Reuters) - Drugmaker Eli Lilly and Co said on Thursday Christi Shaw, president of its bio-medicines business, would leave the company at the end of next month.
More from
Seeking Alpha 07/10/2019 15:47
As a matter of fact, Eli Lilly does not have a clinical program for liver diseases.
More from Seeking Alpha:
NASDAQ 07/09/2019 13:06
Eli Lilly (LLY) Eli Lilly has been sliding lower since peaking in March, breaking below the pivotal 200-day moving average line in early June.
More from NASDAQ:
Korean Biomedical Review 07/01/2019 01:31
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz.
More from Korean Biomedical Review:
Benzinga 06/26/2019 10:22
Fast-Track Designation For Heart Failure Drug Lilly said the FDA granted the Fast Track designation to empagliflozin, which is being evaluated for the reduction of the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
More from Benzinga:
Healio News 06/20/2019 08:00
The other presentation provided an update from the KEYNOTE-189 study, which assessed pembrolizumab (Keytruda, Merck) plus chemotherapy with pemetrexed (Alimta, Eli Lilly) and platinum vs. placebo plus chemotherapy for patients with metastatic nonsquamous NSCLC.
More from Healio News:
Drug Store News 06/17/2019 14:50
Under the terms of the agreement, Lilly will pay Centrexion an upfront payment of $47.5 million and Centrexion may be eligible for up to $575 million in potential development and regulatory milestones.
More from Drug Store News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications